Neogen Corporation

NASDAQ:NEOG

Medical - Diagnostics & Research

Healthcare
$11.08 +1.79%

+$0.16 today

Market cap
$2.42B
Beta
1.80
P/E (TTM)
-3.3
EPS (TTM)
-$2.80
52W Low $4.56High $11.43

Volume 1.79M

Average 2.53M

NEOG Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Neogen CorporationNASDAQ: NEOG

Weighted Avg Shares (Diluted) · Q1 FY2027 · quarter ended Aug 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2027 weighted avg shares (diluted) of 218.1M shares rose 0.5% year over year, in line with the +0.3% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.2% from the prior quarter. Over 3 fiscal years it compounded at +4.8% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +0.5% holds above the trailing-twelve-month pace of +0.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterAug 2026
218.1M+0.2% QoQ
Last fiscal yearMay 2026
217.5M+0.3% YoY
LTMAug 2026
217.73M+0.3% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.5%——
1 year+0.3%——
3-year CAGR+4.8%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2026
217.5M USD
Year-over-year change
+0.3%
4-year CAGR
+19.1%

Weighted Avg Shares (Diluted) vs competitors

How NEOG compares with its peers on the latest reported figures

  • NEOG's LTM Aug 2026 weighted avg shares (diluted) of 217.73M shares is the 4th highest of the 7 companies compared; the peer median is 255.37M shares.
  • Its year-over-year change of +0.3% is the 3rd highest of 7, against a peer median of -1.5%.
  • Over three fiscal years its annual growth of +4.8% compares with a peer median of -0.1%.
NEOG Competitors Peer median
Weighted Avg Shares (Diluted) for NEOG and competitors
Company Period LTM YoY 3-year CAGR
MRKMerck & Co., Inc.LTM Jun 20262.48B -1.9%-0.5%
ELANElanco Animal Health IncorporatedLTM Sep 2026503.83M +1.3%+0.5%
ZTSZoetis Inc.LTM Jun 2026430.48M -4.2%-1.9%
NEOGNeogen CorporationLTM Aug 2026217.73M +0.3%+4.8%
IDXXIDEXX Laboratories, Inc.LTM Sep 202680.27M -1.6%-1.6%
PAHCPhibro Animal Health CorporationLTM Mar 202640.89M +0.6%+0.2%
BCPCBalchem CorporationLTM Sep 202632.22M -1.5%+0.2%
Peer median (excluding NEOG) 255.37M-1.5%-0.1%

Competitors are the stored peer set for NEOG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
FY2026
May 2026
Revenue527.16M822.45M924.22M894.66M870.4M
Cost of Revenue284.15M416.49M461.59M473.29M461.9M
Gross Profit243.01M405.96M462.64M421.38M408.5M
Gross Margin46.1%49.4%50.1%47.1%46.9%
Research & Development17.05M26.04M22.48M21.09M18.4M
Selling, General & Admin167.35M342.4M382.76M401.97M411.7M
Operating Expenses184.4M368.44M385.21M411.96M430.1M
Depreciation & Amortization24.13M90.47M121.23M125.67M116.3M
EBITDA84.34M124.39M182.6M(937.75M)164.9M
EBITDA Margin16.0%15.1%19.8%-104.8%18.9%
Operating Income58.62M37.52M77.43M9.42M(21.6M)
Operating Margin11.1%4.6%8.4%1.1%-2.5%
Interest Income1.34M3.17M6.36M3.11M0
Interest Expense72K55.96M73.39M71.62M57.6M
Other Income / Expenses1.59M(59.56M)(91.73M)(1.14B)12.6M
Income Before Tax60.21M(22.04M)(14.31M)(1.13B)(9M)
Pre-Tax Margin11.4%-2.7%-1.5%-126.7%-1.0%
Income Tax Expense11.9M828K(4.88M)(41.07M)(1.1M)
Net Income48.31M(22.87M)(9.42M)(1.09B)(7.9M)
Net Margin9.2%-2.8%-1.0%-122.1%-0.9%
EPS (Basic)0.45(0.12)(0.04)(5.03)(0.04)
EPS (Diluted)0.45(0.12)(0.04)(5.03)(0.04)
Weighted Avg Shares107.68M188.88M216.48M216.89M217.5M
Weighted Avg Shares (Diluted)108.02M188.88M216.48M216.89M217.5M

Neogen Corporation

NASDAQ:NEOG

Intrinsic Alpha fair value

Locked

Current Price

$11.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.